Header

Skip to main content
Back to Directory
Biotech CorridorRockville, MD

Immunomic Therapeutics

Visit Website
About the Company

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.

Create a free account to see more

Free members can view HQ location, employee count, capabilities, year founded, funding stage, and more.

Sign Up Free →
Key Contacts
Premium members only

Upgrade to Premium to view key contacts including name, title, and verified email.

Upgrade to Premium →
Is this your organization?

Register or log in to claim this listing and manage your company profile.

Register Free Log In
This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.